Finance EXAS Stock Soars And GH Stock Crashes: Battle Of The Colon Cancer Tests Heats UpDecember 16, 20220 Guardant Well being (GH) unveiled pivotal outcomes for its colon cancer-detecting blood check that lagged rival Precise Sciences (EXAS) —…
